Slow Vaccination Rollout Puts EU Strategy Under Scrutiny

Editorial photo #6383904 Economy, Business and Finance

Slow Vaccination Rollout Puts EU Strategy Under Scrutiny

An illustrative image of a medical syringe in front of the logos of various companies working on the Covid-19 vaccine, displayed on a screen. On Tuesday, January 26, 2021, in Dublin, Ireland. (Photo illustration by Artur Widak/NurPhoto)

Photo details

Photo ID
#6383904
Date taken
Location
—
Photographer
Artur Widak/NurPhoto
Category
Economy, Business and Finance
Copyright
© 2026 NurPhoto - Artur Widak/NurPhoto

Related keywords

2021 AstraZeneca Business Finance and Industry COVID-19 COVID-19 Vaccine Colour Image Coronavirus CureVac Disposable EU Economy Editorial Environment Epidemic Essential Services Europe Finance Finance and Economy France GSK Sanofi Germany Healthcare And Medicine Human Interest Image Infectious Disease Injecting Ireland Janssen Pharmaceutica January Lab Logo Medical Occupation Medical Syringe Moderna New Covid Variant Organism Oxford University Pandemic - Illness Pfizer Pfizer-BionTech vaccine Poland Preparations SARS-CoV-2 Science and Technology Security Sputnik V Surgical Equipment Syringe Typescript UK USA Vaccination Vaccine Production Valneva SE Virus Virus Organism WHO business distribution dose environment issue illustration photo impact laboratory mass vaccination mess new variant precaution protection recycling rollout screen showing vaccine vial widespread
Share
Rights-Managed (RM) · Single Editorial Use

License This Image

Configure usage rights. Price adjusts in real time.

One license covers one publication within the parameters you select. Each additional publication (e.g. separate articles, posts, issues) requires its own license. License terms ›

Media Type
Image Size
License Duration
Territory
Page Placement
Monthly Page Views
Print Run / Circulation
Your License Quote
Web & Digital / Small
1 Month · Single Country
€35.00
excl. VAT
or 35 credits
View price breakdown
Base price (3 months)€50.00
License total€35.00

Secure checkout via Stripe & PayPal

Need custom or commercial rights? Contact Sales · [email protected]

© 2026 NurPhoto. All rights reserved. This image is the property of NurPhoto and is protected under international copyright laws.

More like this

View all
An illustrative image of medical syringes in front of a Google logo displayed on a screen....
Slow Vaccination Rollout Puts EU Strategy Under Scrutiny
An illustrative image of medical syringes in front of an AstraZeneca logo displayed on a s...
Slow Vaccination Rollout Puts EU Strategy Under Scrutiny
An illustrative image of medical syringes in front of the logos of various companies worki...
Slow Vaccination Rollout Puts EU Strategy Under Scrutiny
An illustrative image of a medical syringe in front of an AstraZeneca logo displayed on a...
Slow Vaccination Rollout Puts EU Strategy Under Scrutiny
An illustrative image of medical syringes in front of Online Dating And People Connecting...
Slow Vaccination Rollout Puts EU Strategy Under Scrutiny
An illustrative image of medical syringes in front of an AstraZeneca logo displayed on a s...
Slow Vaccination Rollout Puts EU Strategy Under Scrutiny
An illustrative image of a medical syringe in front of a Google logo displayed on a screen...
Slow Vaccination Rollout Puts EU Strategy Under Scrutiny
An illustrative image of medical syringes in front of a Johnson-Johnson logo displayed on...
Slow Vaccination Rollout Puts EU Strategy Under Scrutiny
An illustrative image of a medical syringe in front of a Twitter logo displayed on a scree...
Slow Vaccination Rollout Puts EU Strategy Under Scrutiny
An illustrative image of medical syringes in front of a Twitter logo displayed on a screen...
Slow Vaccination Rollout Puts EU Strategy Under Scrutiny
An illustrative image of medical syringes in front of a Twitter logo displayed on a screen...
Slow Vaccination Rollout Puts EU Strategy Under Scrutiny
An illustrative image of medical syringes in front of an AstraZeneca logo displayed on a s...
Slow Vaccination Rollout Puts EU Strategy Under Scrutiny